Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure

Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients

NCT02344641 ·Status: UNKNOWN ·Phase: NA

A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

NCT00742508 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

NCT03098979 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

NCT04944706 ·Status: COMPLETED ·Phase: PHASE2

SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

NCT05583773 ·Status: RECRUITING ·Phase: PHASE4

An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

NCT06116968 ·Status: COMPLETED ·Phase: PHASE3

A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.

NCT04515290 ·Status: COMPLETED ·Phase: PHASE2

Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease

NCT07268807 ·Status: NOT_YET_RECRUITING

Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure

NCT04468529 ·Status: COMPLETED ·Phase: PHASE3

An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

NCT00813202 ·Status: COMPLETED ·Phase: PHASE3

The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients

NCT04028544 ·Status: UNKNOWN ·Phase: PHASE4

Heart Failure and Anemia

NCT00049985 ·Status: COMPLETED ·Phase: PHASE2

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)

NCT01481402 ·Status: COMPLETED ·Phase: NA

A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure

NCT00303498 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

NCT01798745 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

NCT04814186 ·Status: COMPLETED ·Phase: PHASE4

Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy

NCT01293903 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction

NCT02992288 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

NCT01115855 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

NCT07269717 ·Status: RECRUITING ·Phase: PHASE2

Clinical Study on the Immunomodulatory Effect of Eprolidone on Patients With Chronic Heart Failure

NCT05924958 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure

NCT01120210 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure

NCT01618448 ·Status: COMPLETED ·Phase: PHASE3

A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

NCT06949020 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

NCT04320771 ·Status: TERMINATED ·Phase: PHASE1